Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Essence (BIOE) EBITDA Margin (2020 - 2025)

Historic EBITDA Margin for Bio Essence (BIOE) over the last 6 years, with Q3 2025 value amounting to 10.42%.

  • Bio Essence's EBITDA Margin rose 1191500.0% to 10.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 22.23%, marking a year-over-year increase of 5041100.0%. This contributed to the annual value of 141.83% for FY2024, which is 791700.0% down from last year.
  • According to the latest figures from Q3 2025, Bio Essence's EBITDA Margin is 10.42%, which was up 1191500.0% from 23.63% recorded in Q2 2025.
  • In the past 5 years, Bio Essence's EBITDA Margin ranged from a high of 95.31% in Q4 2023 and a low of 924.3% during Q1 2025
  • For the 5-year period, Bio Essence's EBITDA Margin averaged around 111.83%, with its median value being 73.9% (2022).
  • Within the past 5 years, the most significant YoY rise in Bio Essence's EBITDA Margin was 4193900bps (2025), while the steepest drop was -8256200bps (2025).
  • Bio Essence's EBITDA Margin (Quarter) stood at 93.3% in 2021, then skyrocketed by 59bps to 38.64% in 2022, then skyrocketed by 347bps to 95.31% in 2023, then tumbled by -97bps to 2.61% in 2024, then skyrocketed by 299bps to 10.42% in 2025.
  • Its EBITDA Margin was 10.42% in Q3 2025, compared to 23.63% in Q2 2025 and 924.3% in Q1 2025.